ArticleJournal of thoracic disease2019

Relationship between performance status or younger age and osimertinib therapy in T790M-positive NSCLC: are the available data convincing?

Umberto Malapelle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.